Focus Partners Wealth Reduces Stock Position in Astera Labs, Inc. $ALAB

Focus Partners Wealth decreased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 25.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 325,243 shares of the company’s stock after selling 108,788 shares during the period. Focus Partners Wealth owned about 0.19% of Astera Labs worth $63,652,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Brevan Howard Capital Management LP boosted its stake in shares of Astera Labs by 151.1% during the third quarter. Brevan Howard Capital Management LP now owns 186,984 shares of the company’s stock valued at $36,611,000 after purchasing an additional 112,518 shares during the period. Capula Management Ltd purchased a new position in Astera Labs in the 3rd quarter worth about $338,000. Cinctive Capital Management LP bought a new stake in Astera Labs during the 3rd quarter valued at about $1,842,000. Clear Street Group Inc. bought a new stake in Astera Labs during the 3rd quarter valued at about $60,744,000. Finally, Ausdal Financial Partners Inc. lifted its holdings in Astera Labs by 11.1% during the 3rd quarter. Ausdal Financial Partners Inc. now owns 3,158 shares of the company’s stock valued at $618,000 after buying an additional 316 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of research reports. Raymond James Financial initiated coverage on shares of Astera Labs in a research report on Friday, November 21st. They set a “hold” rating on the stock. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Northland Securities raised their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. BNP Paribas Exane assumed coverage on Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating for the company. Finally, Loop Capital began coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average target price of $202.22.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the sale, the general counsel directly owned 128,084 shares in the company, valued at $15,046,027.48. This represents a 7.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 224,292 shares of company stock worth $27,676,069. Insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $127.48 on Tuesday. The company has a 50 day moving average price of $147.10 and a 200-day moving average price of $167.60. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a market capitalization of $21.70 billion, a PE ratio of 104.49, a PEG ratio of 2.37 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs’s revenue was up 91.8% compared to the same quarter last year. During the same period last year, the company posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.